AB081. Effects of combination therapy of Tamoxifen, L-carnitine and daily PDE5 inhibitors in the Peyronie’s disease

OBJECTIVE: This study was designed to evaluate the efficacy of combination therapy of Tamoxifen, L-carnitine and daily PDE5 inhibitors and to compare with Potassium para-aminobenzoate (Potaba) monotherapy in the medical treatment of Peyronie’s disease. METHODS: From January 2011 to December 2014, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Jae Il, Park, Tae Yong, Jeong, Hyeong Guk, Park, Jong Jin, Chae, Ji Yun, Kim, Jong Wook, Oh, Mi Mi, Park, Hong Seok, Kim, Je Jong, Moon, Du Geon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2016
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842744/
http://dx.doi.org/10.21037/tau.2016.s081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842744/
http://dx.doi.org/10.21037/tau.2016.s081

Ejemplares similares